cns.jpg (2811 bytes)



Journal Home
Editorial Board
Instructions for Contributors
Subscription Rates

Neva Press, Inc. 2005

CNS Drug Reviews

Table of Contents

Volume 1, No. 1


1 Preclinical Pharmacology of ABT-418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease
Stephen P. Arneric, David J. Anderson, Anthony W. Bannon, Clark A. Briggs, Jerry J. Buccafusco, Jorge D. Brioni, John B. Cannon, Michael W. Decker, Diana Donnelly-Roberts, Murali Gopalakrishnan, Mark W. Holladay, Jaroslav Kyncl, Kennan C. Marsh, James Pauly, Richard J. Radek, A. David Rodrigues and James P. Sullivan
27 CI-1002, A Combined Acetylcholinesterase Inhibitor and Muscarinic Antagonist
Mark R. Emmerling, Vlad E. Gregor, Michael J. Callahan, Roy D. Schwarz, Jeff D. Scholten, Edward L. Orr, Thomas Pugsley, Catherine J. Moore, Charlotte Raby, Sharie L. Myers, Robert E. Davis and Juan Jaen
50 (ICI 204,636): A Dibenzothiazepine Atypical Antipsychotic. Review of Preclinical Pharmacology and Highlights of Phase II Clinical Trials.
Jeffrey M. Goldstein and Lisa A. Arvantis
74 Modulation of the NMDA Receptor Complex by D-cycloserine
Mark G. Baxter and Thomas H. Lanthorn
91 Neuroprotective Action of Nicardipine Hydrochloride
Minoru Yamamoto and Tohichi Takenaka
107 Evaluation of Cognition-enhancing Drugs: Utility of the Model System of Eyeblink Classical Conditioning
Diana S. Woodruff-Pak